AUD 1.0
(-3.85%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 155.02 Million AUD | -4.4% |
2023 | 162.15 Million AUD | 50.74% |
2022 | 107.57 Million AUD | 40.49% |
2021 | 76.56 Million AUD | 6.56% |
2020 | 71.85 Million AUD | 6.03% |
2019 | 67.76 Million AUD | 18.49% |
2018 | 57.19 Million AUD | 5.34% |
2017 | 54.29 Million AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q4 | 39.3 Million AUD | 0.0% |
2024 FY | 155.02 Million AUD | -4.4% |
2024 Q2 | 76.41 Million AUD | 100.0% |
2024 Q1 | 38.2 Million AUD | -53.46% |
2024 Q3 | 39.3 Million AUD | -48.56% |
2023 Q2 | 80.06 Million AUD | 100.0% |
2023 Q1 | 40.03 Million AUD | -37.32% |
2023 FY | 162.15 Million AUD | 50.74% |
2023 Q4 | 82.09 Million AUD | 100.0% |
2023 Q3 | 41.04 Million AUD | -48.73% |
2022 Q3 | 31.93 Million AUD | -26.95% |
2022 Q2 | 43.71 Million AUD | 100.0% |
2022 Q1 | 21.85 Million AUD | -44.18% |
2022 FY | 107.57 Million AUD | 40.49% |
2022 Q4 | 63.86 Million AUD | 100.0% |
2021 Q1 | 18.7 Million AUD | -47.62% |
2021 FY | 76.56 Million AUD | 6.56% |
2021 Q4 | 39.15 Million AUD | 100.0% |
2021 Q3 | 19.57 Million AUD | -47.67% |
2021 Q2 | 37.41 Million AUD | 100.0% |
2020 Q1 | 18.07 Million AUD | 0.0% |
2020 FY | 71.85 Million AUD | 6.03% |
2020 Q4 | 35.71 Million AUD | 100.0% |
2020 Q3 | 17.85 Million AUD | -50.6% |
2020 Q2 | 36.14 Million AUD | 100.0% |
2019 FY | 67.76 Million AUD | 18.49% |
2018 FY | 57.19 Million AUD | 5.34% |
2017 FY | 54.29 Million AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Austco Healthcare Limited | 58.15 Million AUD | -166.578% |
Nanosonics Limited | 171.56 Million AUD | 9.64% |
Osteopore Limited | 2.21 Million AUD | -6891.178% |
SDI Limited | 111.2 Million AUD | -39.402% |